Empaglif-M (Empagliflozin INN & Metformin Hydrochloride BP)
Therapeutic Group : Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors Presentation: Empaglif-M 5/500 Tablet: Each film-coated tablet contains Empagliflozin INN 5 mg & Metformin Hydrochloride BP 500 mg. Pharmacology: Empaglif-M combines 2 anti-hyperglycemic agents with complementary mechanisms of action to improve glycemic control in patients with type 2 diabetes: Empagliflozin, a sodium-glucose co-transporter 2 (SGLT2) inhibitor, and metformin, […]